A61K 31/4709
Non-condensed quinolines and containing further heterocyclic rings
A61K31/4709 (Non-condensed quinolines and containing further heterocyclic rings) appears on 2,600 US grants and 4,858 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,600
- Published applications
- 4,858
- Assignees
- 1,776
- Inventors
- 10,923
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 7 | 0 |
| 1996 | 9 | 0 |
| 1997 | 19 | 0 |
| 1998 | 15 | 0 |
| 1999 | 20 | 0 |
| 2000 | 25 | 0 |
| 2001 | 26 | 7 |
| 2002 | 29 | 41 |
| 2003 | 31 | 96 |
| 2004 | 30 | 97 |
| 2005 | 31 | 84 |
| 2006 | 24 | 98 |
| 2007 | 28 | 99 |
| 2008 | 28 | 85 |
| 2009 | 37 | 114 |
| 2010 | 45 | 142 |
| 2011 | 57 | 142 |
| 2012 | 86 | 139 |
| 2013 | 119 | 264 |
| 2014 | 155 | 268 |
| 2015 | 180 | 310 |
| 2016 | 168 | 279 |
| 2017 | 223 | 269 |
| 2018 | 156 | 221 |
| 2019 | 179 | 274 |
| 2020 | 164 | 238 |
| 2021 | 149 | 236 |
| 2022 | 139 | 286 |
| 2023 | 99 | 268 |
| 2024 | 127 | 272 |
| 2025 | 107 | 282 |
| 2026 | 86 | 247 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Assisted loading of hydrophobic molecules into liposomes6 Oct 2026US 12,751,922 B2University of Connecticut
- Methods and compositions for treating fungal infections6 Oct 2026US 12,751,944 B2Neoculi Pty Ltd
- Quinazoline derivative, or preparation method therefor and use thereof6 Oct 2026US 12,751,952 B2Shanghai Aryl Pharmtech Co., Ltd.
- Spirotricycle RIPK1 inhibitors and methods of uses thereof6 Oct 2026US 12,753,190 B2Merck Sharp & Dohme Corp.
- Use of composition containing cilostazol in cerebrovascular diseases29 Sep 2026US 12,746,234 B2Neurodawn Pharmaceutical Co., Ltd.
- Uric acid transporter agonist compound, pharmaceutical composition, and preparation method therefor and use thereof8 Oct 2026US 2026/0308136 A1Hangzhou E & J Biopharmaceutical Technology Co., Ltd.
- 5-ht2a receptor inverse agonist, and preparation method therefor and use thereof8 Oct 2026US 2026/0308142 A1Luye Innomind Pharma Shijiazhuang Co., Ltd.
- Triazolyl-containing compounds8 Oct 2026US 2026/0308146 A1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- Replicon dna, cloning vector, screening kit, screening method, anti-nobecov-irus agent, beta-coronavirus proliferation inhibitor, pan beta-coronavirus inhibitor, virus proliferation inhibitor, hepatitis c virus proliferation inhibitor, and method for screening therapeutic agent for viral infectious disease8 Oct 2026US 2026/0308206 A1Kagoshima University
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine288US 5,238,944 ARiker Laboratories, Inc. · 1993
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase209US 5,409,930 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1995